Legal Representation
Attorney
Michael R Rizzo
USPTO Deadlines
Application History
41 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Dec 16, 2024 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
Dec 16, 2024 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
Jul 26, 2024 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
Apr 13, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Apr 12, 2024 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
Apr 12, 2024 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
Apr 12, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Oct 5, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Oct 3, 2023 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
Oct 3, 2023 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
Oct 3, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Mar 10, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Mar 8, 2023 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
Mar 8, 2023 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
Mar 8, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Oct 21, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Oct 19, 2022 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Oct 19, 2022 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Oct 19, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Apr 16, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Apr 14, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Apr 14, 2022 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Apr 14, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Nov 9, 2021 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Sep 14, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Sep 14, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Aug 26, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Aug 11, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Aug 11, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Aug 11, 2021 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
Aug 11, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Aug 11, 2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Jul 20, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jul 19, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Jul 19, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Mar 31, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Mar 31, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Mar 31, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Mar 31, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Jan 28, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Nov 21, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Information and data compiling and analyzing relating to business management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; compilation and analysis of biostatistics for business or commercial purposes in the field of clinical trials; all of the foregoing excluding real estate services, real estate development, management and maintenance services, real estate rental services, real estate financial services, architecture services, and engineering services
Class 042
medical and scientific research, namely, conducting clinical trials; pharmaceutical drug development services; pharmaceutical testing services
Classification
International Classes
035
042